For CKD patients not receiving dialysis treatment, patients must have an Hb level ≤ 10 g/dL and serum ferritin < 100 ng/mL or TSAT < 20% to be reimbursed for IV iron formulations. Here, GSTM1 is linked to chronic kidney disease.